[Primary type V hyperlipidemia].
Oikawa
S
S
Third Department of Internal Medicine, Tohoku University School of Medicine.
D000434:Alcoholic Beverages / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D004038:Diet, Reducing; D005081:Exercise Therapy; D006801:Humans; D006954:Hyperlipoproteinemia Type V / Q000175:diagnosis / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use
D015415:Biomarkers; D015243:Cholesterol, VLDL; D002914:Chylomicrons; D000960:Hypolipidemic Agents